/Investor DB

Eight Roads Ventures — 2020 Investments

5 investments dated 2020 · listed companies and verified rows first · show all

Adageneadagene.cominNASDAQ: ADAGJan 2020

Adagene is a clinical-stage immunotherapy company that uses computational biology and artificial intelligence to discover and design therapeutic antibodies for cancer treatment.

AI & Machine LearningBiotech

Co-investorsF-Prime CapitalGeneral AtlanticToba CapitalSequoia Capital

MineralTreemineraltree.comin𝕏Series A · Sep 2020 · $9.3M

MineralTree offers accounts payable automation for finance teams, covering invoice capture, approval routing, payment authorization, and payment optimization.

Enterprise SoftwareFintechSaaSBoston, US

BC Krishna(Executive Officer, Director)inMicah RemleyinBill Price(Executive Officer)in

BoardRaj Dugar(Director)Maria Cirino(Director)inGreg Dracon(Director)in

Co-investors.406 VenturesF-Prime CapitalGreat Hill Partners

Otriumotrium.comSeries B · May 2020 · $26M

Otrium operates an online marketplace offering discounted fashion and apparel, featuring brand collaborations and seasonal collections with promotional pricing.

Circular EconomyE-commerceMarketplacesRetail Tech

Milan Daniels(Founder)inFrank Van ValdereninMax Klijnstra(Founder)Milan Daniels Max Klijnstra(Founder)

Co-investorsAngel Capital ManagementBond Capital ManagementIndex VenturesKeadyn

Tibbertibber.comin𝕏Series B · Nov 2020 · $65M

Tibber is a digital energy company that helps customers reduce electricity consumption and manage energy costs through real-time pricing visibility and smart home integrations.

CleantechEnergyIoTSaaSOslo, NO

Daniel Lindén(Founder)inEdgeir Vårdal Aksnes(Founder)Edgeir Aksnes(Founder)

Co-investorsAggregate MediaBalderton CapitalCreandumEviny VenturesSumma EquityWellstreet+1 more

Topprtoppr.comJul 2020

India's leading K-12 tutoring app

Zishaan Hayath(Founder)inHemanth Goteti(Founder)

Co-investorsElevation CapitalKaizenvestAlteria CapitalHelion Venture PartnersKaizen Private EquitySAIF

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.